Definitive Contract 75N93019C00026
Award Date
8/14/19
Potential Completion Date
8/18/20
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Crosslife Technologies Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carlsbad, CA 92010, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $216,444 Small Business Innovation Research (SBIR) Phase I contract to Crosslife Technologies Inc., a self-certified small disadvantaged business, to conduct research and development on diagnostics to enable the detection and elimination of malaria and neglected tropical diseases. The contract was awarded under the NIH/CDC SBIR Contract Solicitation PHS...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $299,993 Small Business Innovation Research (SBIR) Phase I contract to Chromologic LLC, a minority-owned and Asian-Indian American-owned limited liability company, for the development of "Mobile Health Point-of-Care Diagnostics for Malaria." This contract is focused on research and development of rapid diagnostic technologies for malaria, a...
This $221,889 firm fixed-price SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a biopharmaceutical company, for "Diagnostics to Enable Malaria and Neglected Tropical Diseases". The contract originated from the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS 2018-1, which sought...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Crosslife Technologies Inc., a for-profit small business, for $299,987.00. The contract is for the development of a point of care nucleic acids test for the detection of the liver flukes Opisthorchis viverrini and Clonorchis. This contract is a Definitive Contract with a Firm Fixed Price pricing type. The...
This is a $299,986 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Big Eye Diagnostics Inc., a small business manufacturer, for the development and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is part of NIAID's Small Business Innovation Research (SBIR) program, which provides funding to small businesses for innovative research and development. The objective is to create rapid,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) under the Department of Health and Human Services. The contract, valued at $225,000.00, was awarded to Hemex Health Inc., a for-profit medical diagnostics company that develops affordable point-of-care tests for diseases like sickle cell and malaria. The contract is focused on developing diagnostic...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $300,000 Firm Fixed Price Definitive Contract to L2 Diagnostics LLC, a small business, for the NOVEL DIAGNOSTIC BIOMARKERS DISCOVERY AND VALIDATION FOR MALARIA SBIR PHASE I effort. This Small Business Innovation Research (SBIR) Phase I contract has a performance period ending on November 30, 2025 and is set aside for total small business participation. L2 Diagnostics LLC is a for-profit limited...
This is a $299,820.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Biological Mimetics, Inc. for a Phase I Small Business Innovation Research (SBIR) project to develop a CRISPR-based diagnostic test for parasites. The contract is not set aside. Biological Mimetics is a biotechnology firm that conducts research and development on infectious diseases, vaccines, diagnostics, and...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase II contract to Nowdiagnostics, Inc., a small disadvantaged business, for a multiplexed remote system for filovirus disease surveillance. The firm-fixed-price contract, with a potential value of $2,431,860.00, was awarded on September 20, 2018 and has a completion date of September 30, 2022....
This is a $299,408 SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Darwin Biosciences, Inc., a woman-owned small business. The contract is for the development of rapid diagnostic assays for self-monitoring of acute or rebound HIV-1 infection. As a Small Business Innovation Research (SBIR) award, this contract is set aside for small businesses. The contract has a firm fixed price structure and a period of performance...